{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:14:45Z","timestamp":1792800885241,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pegaspargase-related severe acute pancreatitis (SAP) combined with persistent multiple organ dysfunction syndrome (MODS) is a life-threatening adverse reaction in children receiving acute lymphoblastic leukemia (ALL) chemotherapy. Standard intensive supportive care often fails to halt progressive organ damage, while clinical data regarding therapeutic plasma exchange (TPE) as a rescue intervention in pediatric populations remain scarce. Guidelines released by the American Society for Apheresis (ASFA) do not recommend routine TPE administration for all patients diagnosed with acute pancreatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective analysis describes a 7-year-old female patient newly diagnosed with B-cell precursor ALL, who developed SAP and refractory MODS 48\u00a0h after pegaspargase infusion. SAP diagnosis complied with the 2012 Revised Atlanta Classification, and MODS severity was quantified using the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) scoring system. After 24\u00a0h of maximum standardized supportive care failed to reverse clinical deterioration, a single standardized TPE session was implemented. A chronological care timeline and serial laboratory biomarker table were constructed to quantify the dynamic therapeutic response of the patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Non-invasive ventilation was applied to relieve intractable respiratory distress; invasive mechanical ventilation and vasopressor support were unnecessary throughout hospitalization. Severe epigastric pain disappeared within six hours after TPE, and respiratory support was successfully withdrawn 24\u00a0h post-intervention. Significant declines in pancreatic enzyme levels, extreme hypertriglyceridemia and systemic inflammatory mediators were observed, alongside full recovery of respiratory, renal and hematologic organ function. No adverse events linked to apheresis occurred during treatment. The patient recovered completely from pancreatitis, resumed scheduled maintenance chemotherapy, and maintained minimal residual disease (MRD)-negative hematologic remission at the 3-month outpatient follow-up. Clinical improvement was mainly attributed to extracorporeal clearance of triglycerides and pro-inflammatory cytokines; due to the pharmacokinetic characteristics of pegaspargase at 48\u00a0h post-administration, the removal of this chemotherapeutic agent via TPE was negligible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Single-session TPE can rapidly reverse refractory MODS triggered by pegaspargase-induced SAP when conventional supportive treatments show no efficacy. Nevertheless, complete clinical recovery cannot be solely attributed to apheresis, as continuous multi-organ supportive management was provided throughout the treatment course. TPE can be regarded as a targeted rescue strategy for carefully selected critically ill pediatric patients, yet existing meta-analyses and ASFA consensus statements do not support its universal routine use. Large-scale prospective pediatric cohort studies are required to determine the optimal timing and treatment cycles of TPE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-07273-9","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:49:42Z","timestamp":1785890982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-session therapeutic plasma exchange as salvage therapy for pegaspargase-induced severe acute pancreatitis accompanied by multiple organ dysfunction in a pediatric patient with B-cell precursor acute lymphoblastic leukemia: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Jianhua","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"9798","key":"7273_CR1","first-page":"719","volume":"378","author":"CH Pui","year":"2011","unstructured":"Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2011;378(9798):719\u201331.","journal-title":"Lancet"},{"issue":"15","key":"7273_CR2","first-page":"1654","volume":"35","author":"S Jeha","year":"2017","unstructured":"Jeha S, Pei D, Coustan-Smith E, et al. Pegaspargase versus native Escherichia coli asparaginase in childhood acute lymphoblastic leukemia. J Clin Oncol. 2017;35(15):1654\u201361.","journal-title":"J Clin Oncol"},{"issue":"7","key":"7273_CR3","first-page":"e512","volume":"42","author":"C Liu","year":"2020","unstructured":"Liu C, Zhang L, Yang Y, et al. Toxicities of pegaspargase in pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2020;42(7):e512\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"7273_CR4","doi-asserted-by":"crossref","first-page":"e27789","DOI":"10.1002\/pbc.27622","volume":"66","author":"C Chen","year":"2019","unstructured":"Chen C, Wang L, Li J, et al. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2019;66(5):e27789.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"7273_CR5","first-page":"e28876","volume":"68","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi H, Tanaka Y, Kato K, et al. Severe pancreatitis after asparaginase in pediatric ALL: a nationwide survey. Pediatr Blood Cancer. 2021;68(11):e28876.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"7273_CR6","first-page":"192","volume":"44","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Q, Zhao H, et al. Clinical characteristics and risk factors of asparaginase-related pancreatitis. J Pediatr Hematol Oncol. 2022;44(3):192\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"7273_CR7","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1097\/PCC.0000000000002570","volume":"21","author":"A Smith","year":"2020","unstructured":"Smith A, Johnson K, Brown N, et al. Delayed diagnosis of severe pancreatitis in pediatric leukemia patients. Pediatr Crit Care Med. 2020;21(12):e509.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"7273_CR8","doi-asserted-by":"crossref","first-page":"103345","DOI":"10.1016\/j.transci.2021.103345","volume":"61","author":"S Schwerdt","year":"2022","unstructured":"Schwerdt S, K\u00fchne M, Schwarz A, et al. Therapeutic plasma exchange in pediatric critical care. Transfus Apher Sci. 2022;61(3):103345.","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"7273_CR9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/CCM.0000000000003904","volume":"47","author":"H Wang","year":"2019","unstructured":"Wang H, Li Y, Zhang Y, et al. Therapeutic plasma exchange for cytokine storm in severe acute pancreatitis. Crit Care Med. 2019;47(10):1324\u201331.","journal-title":"Crit Care Med"},{"issue":"3","key":"7273_CR10","first-page":"300","volume":"49","author":"G Uomo","year":"2020","unstructured":"Uomo G, et al. Plasma exchange for acute pancreatitis: a systematic review and meta-analysis. Pancreas. 2020;49(3):300\u20136.","journal-title":"Pancreas"},{"issue":"2","key":"7273_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pbc.20332","volume":"45","author":"V Laugel","year":"2005","unstructured":"Laugel V, et al. Severe acute pancreatitis in children receiving asparaginase. Pediatr Blood Cancer. 2005;45(2):212\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"7273_CR12","doi-asserted-by":"publisher","first-page":"e2320802","DOI":"10.1001\/jamanetworkopen.2023.20802","volume":"6","author":"VP Singh","year":"2023","unstructured":"Singh VP, et al. Early plasmapheresis for hypertriglyceridemia-associated acute pancreatitis. JAMA Netw Open. 2023;6(6):e2320802.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"7273_CR13","first-page":"e29967","volume":"70","author":"E van der Harst","year":"2023","unstructured":"van der Harst E, et al. Asparaginase-induced pancreatitis in pediatric ALL: updated review. Pediatr Blood Cancer. 2023;70(11):e29967.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"7273_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis\u20142012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102\u201311.","journal-title":"Gut"},{"issue":"7","key":"7273_CR15","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","volume":"41","author":"S Leteurtre","year":"2013","unstructured":"Leteurtre S, Duhamel A, Grandbastien B, et al. PELOD-2: an update of the Pediatric Logistic Organ Dysfunction score. Crit Care Med. 2013;41(7):1761\u20139.","journal-title":"Crit Care Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07273-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:48:07Z","timestamp":1790833687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07273-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7273"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07273-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective single-case report only retrospectively sorted routine inpatient medical records, without additional collection, testing or secondary analysis of biological specimens, and no prospective interventional research was performed. The Institutional Review Board of Liaocheng People\u2019s Hospital granted an exemption from formal ethical review for this work, as the study only used fully de-identified clinical data with minimal privacy risk and no additional biological sample testing. Written informed consent for clinical data analysis was obtained from the patient\u2019s legal guardians. All identifiable personal information, admission numbers and characteristic imaging markers were completely de-identified to fully protect patient privacy.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written permission to publish anonymized clinical data, laboratory results and imaging descriptions was acquired from the patient\u2019s parents prior to manuscript submission. The patient is a minor under 18 years of age.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"931"}}